USA – FDA details approach for finding optimal dosages for new cancer drugs
The US Food and Drug Administration (FDA) has issued a draft guidance to help sponsors identify the optimal dosage for cancer drugs in clinical development and in it, the agency recommends a new approach in selecting such dosages for modern, targeted oncology drugs.
More information on the RIS.WORLD Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (19 avril 2023). USA – FDA details approach for finding optimal dosages for new cancer drugs. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o68y





